Genetic and Environmental Influences on Transitions in Drug Use

1999/11/01 by Ming T. Tsuang, Michael J. Lyons, Rebecca M. Harley +6 · 25 citations
Medicine · Psychology · #Substance Abuse Treatment and Outcomes #Cognitive Abilities and Testing #Child and Adolescent Psychosocial and Emotional Development

paper · doi:10.1023/a:1021635223370

Cited by

• Molecular genetics of addiction vulnerability. [europepmc]
• Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions. [europepmc]
• Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism. [europepmc]
• Evidence for a two-stage model of dependence using the NESARC and its implications for genetic association studies. [europepmc]
• Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years. [europepmc]
• Chronic stress, drug use, and vulnerability to addiction. [europepmc]
• Predicting treatment outcome in stimulant dependence. [europepmc]
• Prevalence and correlates of dual diagnoses in U.S. Latinos. [europepmc]
• Modeling the genetic and environmental association between peer group deviance and cannabis use in male twins. [europepmc]
• Pathways to cannabis abuse: a multi-stage model from cannabis availability, cannabis initiation and progression to abuse. [europepmc]
• Common genetic influences on the timing of first use for alcohol, cigarettes, and cannabis in young African-American women. [europepmc]
• Genetically correlated effects of selective breeding for high and low methamphetamine consumption. [europepmc]
• A cotwin-control analysis of drug use and abuse/dependence risk associated with early-onset cannabis use. [europepmc]
• Cocaine abuse versus cocaine dependence: cocaine self-administration and pharmacodynamic response in the human laboratory. [europepmc]
• Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability. [europepmc]
• Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. [europepmc]
• Dose preference and dose escalation in extended-access cocaine self-administration in Fischer and Lewis rats. [europepmc]
• Neuroplasticity, axonal guidance and micro-RNA genes are associated with morphine self-administration behavior. [europepmc]
• Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors. [europepmc]
• Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genes. [europepmc]
• Epidemiology of the U.S. opioid crisis: the importance of the vector. [europepmc]
• The Genomics of Opioid Addiction Longitudinal Study (GOALS): study design for a prospective evaluation of genetic and non-genetic factors for development of and recovery from opioid use disorder. [europepmc]
• From Enchantment to Disillusion: A Narrative Exploration of Cannabis Use Disorder Among Young Israeli Combat Veterans. [europepmc]
• Methylation of the serotonin transporter gene moderates the depressive subjective effect of cocaine. [europepmc]
• Cocaine Use Disorder (CUD): Current Clinical Perspectives. [europepmc]